Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons

British Journal of Pharmacology

Volumn 131, Issue 4, 2000, Pages 711-720

  Bastianetto, Stéphane ^a   Zheng, Wen Hua ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cyclo oxygenase; Lipoxygenase; Neuroprotection; Nitric oxide; Protein kinase C; Quercetin; Red wine; Resveratrol

Indexed keywords

ALPHA TOCOPHEROL; CATECHIN; CYCLOOXYGENASE 2; LINSIDOMINE; LIPOXYGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; POLYPHENOL; PROTEIN KINASE C; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; TROLOX C;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; ENZYME ACTIVITY; HEART PROTECTION; HIPPOCAMPUS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; WINE;

EID: 0035235476     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703626     Document Type: Article

References (58)

1. ANDRIAMBELOSON, E., KLESCHYOV, A.L., MULLER, B., BERETZ, A., STOCLET, J.C. & ANDRIANTSITOHAINA, R. (1997). Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br. J. Pharmacol., 120, 1053-1058.
2. BASTIANETTO, S., ZHENG, W.H. & QUIRION, R. (2000). The ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J. Neurochem., 74, 2268-2277.
3. BELGUENDOUZ, L., FREMONT, L. & LINARD, A. (1997). Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol., 53, 1347-1355.
4. BERTELLI, A., BERTELLI, A.A., GOZZINI, A. & GIOVANNINI, L. (1998). Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Under Exp. Clin. Res., 24, 133-138.
5. BERTELLI, A.A., GIOVANNINI, L., STRADI, R., URIEN, S., TILLEMENT, J.P. & BERTELLI, A. (1996). Kinetics of trans- and cis-resveratrol (3,4′,5-trihydroxystilbene) after red wine oral administration in rats. Int. J. Clin. Pharmacol. Res., 16, 77-81.
6. CELOTTI, E., FERRARINI, R., ZIRONI, R. & CONTE, L.S. (1996). Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J. Chromato., 730, 47-52.
7. CHO, H., UEDA, M., TAMAOKA, M., HAMAGUCHI, M., AISAKA, K., KISO, Y., INOUE, T., OGINO, R., TATSUOKA, T., ISHIHARA, T., NOGUCHI, T., MORITA, I. & MUROTA, S. (1991). Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. J. Med. Chem., 34, 1503-1505.
8. DAWSON, V.L. & DAWSON, T.M. (1996). Nitric oxide neurotoxicity. J. Chem. Neuroanat., 10, 179-190.
9. DAWSON, V.L., DAWSON, T.M., LONDON, E.D., BREDT, D.S. & SNYDER, S.H. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A., 88, 6368-6371.
10. DIXON, R.A. (1990). Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature, 343, 282-284.
11. FLOYD, R.A. (1999). Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med., 222, 236-245.
12. FORMICA, J.V. & REGELSON, W. (1995). Review of the biology of quercetin and related bioflavonoids. Food & Chem. Toxicol., 33, 1061-1080.
13. FURUTA, A., PRICE, D.L., PARDO, C.A., TRONCOSO, J.C., XU, Z.S., TANIGUCHI, N. & MARTIN, L.J. (1995). Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am. J. Pathol., 146, 357-367.
14. FUTAKI, N., TAKAHASHI, S., YOKOYAMA, M., ARAI, I., HIGUCHI, S. & OTOMO, S. (1994). NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59.
15. GARCIA-GARCIA, J., MICOL, V., DE GODOS, A. & GOMEZ-FERNANDEZ, J.C. (1999). The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity. Arch. Biochem. Biophys., 372, 382-388.
16. GOLDBERG, D., TSANG, E., KARUMANCHIRI, A., DIAMANDIS, E., SOLEAS, G. & NG, E. (1996). Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal. Chem., 68, 1688-1694.
17. HAYEK, T., FUHRMAN, B., VAYA, J., ROSENBLAT, M., BELINKY, P., COLEMAN, R., ELIS, A. & AND AVIRAM, M. (1997). Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arteriosclerosis Thromb. Vasc. Biol., 17, 2744-2752.
18. HERTOG, M.G.L., HOLLMAN, P.C.H. & VAN DE PUTTE, B. (1993). Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. J. Agric. Food Chem., 41, 1242-1246.
19. HOBBS, A.J., HIGGS, A. & MONCADA, S. (1999). Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol., 39, 191-220.
20. HOLZHUTTER, H.G., WIESNER, R., RATHMANN, J., STOSSER, R. & KUHN, H. (1997). A kinetic model for the interaction of nitric oxide with a mammalian lipoxygenase. Eur. J. Biochem., 245, 608-616.
21. HUK, I., BROVKOVYCH, V., NANOBASH VILI, J., WEIGEL, G., NEUMAYER, C., PARTYKA, L., PATTON, S. & MALINSKI, T. (1998). Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br. J. Surg., 85, 1080-1085.
22. INANAMI, O., WATANABE, Y., SYUTO, B., NAKANO, M., TSUJI, M. & KUWABARA, M. (1998). Oral administration of (-)catechin protects against ischemia-reperfusion-induced neuronal death in the Gerbil. Free Rad. Res., 29, 359-365.
23. KIM, H.K., CHEON, B.S., KIM, Y.H., KIM, S.Y. & KIM, H.P. (1999). Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem. Pharmacol., 58, 759-765.
24. KIMURA, Y., OKUDA, H. & ARICHI, S. (1985). Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim. Biophys. Acta., 834, 275-278.
25. KOSHIMURA, K., MURAKAMI, Y., TANAKA, J. & KATO, Y. (1998). Self-protection of PC12 cells by 6R-tetrahydrobiopterin from nitric oxide toxicity. J. Neurosci. Res., 54, 664-672.
26. KOSTYUK, V.A. & POTAPOVICH, A.I. (1998). Antiradical and chelating effects in flavonoid protection against silica-induced cell injury. Arch. Biochem. & Biophys., 355, 43-48.
27. LEE, S.F. & LIN, J.K. (1997). Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutrition Cancer, 28, 177-183.
28. LIU, Y., PETERSON, D.A., KIMURA, H. & SCHUBERT, D. (1997). Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-22,5-diphenyltetrazoliumbromide (MTT) reduction. J. Neurochem., 69, 581-593.
29. MACCARRONE, M., LORENZON, T., GUERRIERI, P. & AGRO, A. (1999). Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur. J. Biochem., 265, 27-34.
30. MAIESE, K., BONIECE, I., SKURAT, K. & WAGNER, J.A. (1993). Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia. J. Neurosci. Res., 36, 77-87.
31. MANN, D.M., YATES, P.O. & MARCYNIUK, B. (1986). A comparison of nerve cell loss in cortical and subcortical structures in Alzheimer's disease. J. Neurol., Neurosurg. Psych., 49, 310-312.
32. MATTSON, M.P., BARGER, S.W., BEGLEY, J.G. & MARK, R.J. (1995). Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Meth. Cell Biol., 46, 187-216.
33. MENARD, L., PILOTE, S., NACCACHE, P.H., LAVIOLETTE, M. & BORGEAT, P. (1990). Inhibitory effects of MK-886 on arachidonic acid metabolism in human phagocytes. Br. J. Pharmacol., 100, 15-20.
34. MOOSMANN, B. & BEHL, C. (1999). The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. U.S.A., 96, 8867-8872.
35. NANJO, F., MORI, M., GOTO, K. & HARA, Y. (1999). Radical scavenging activity of tea catechins and their related compounds. Biosci. Biotech. Biochem., 63, 1621-1623.
36. OBISESAN, T.O., HIRSH, R., KOSOKO, O., CARLSON, L. & PARROTT, M. (1998). Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1. J. Am. Ger. Soc., 46, 1-7.
37. ORGOGOZO, J.M., DARTIGUES, J.F., LAFONT, S., LETENNEUR, L., COMMENCES, D., SALOMON, R., RENAUD, S. & BRETELER, M.B. (1997). Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Revue Neurologique, 153, 185-192.
38. PACE-ASCIAK, C.R., HAHN, S., DIAMANDIS, E.P., SOLEAS, G. & GOLDBERG, D.M. (1995). The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and cicosanoid synthesis: implications for protection against coronary heart disease. Clin. Chim. Acta., 235, 207-219.
39. PANNALA, A.S., RICE-EVANS, C.A., HALLIWELL, D. & SINGH, S. (1997). Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem. Biophys. Res. Comm., 232, 164-168.
40. PLUMB, G.W., DE PASCUAL-TERESA, S., SANTOS-BUELGA, C., CHEYNIER, V. & WILLIAMSON, G. (1998). Antioxidant properties of catechins and proanthocyanidins: effect of polymerisation, galloylation and glycosylation. Free Rad. Res., 29, 351-358.
41. RAO, A.M., HATCHER, J.F., KINDY, M.S. & DEMPSEY, R.J. (1999). Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils. Neurochem. Res., 24, 1225-1232.
42. RENAUD, S. & DE LORGERIL, M. (1992). Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet, 339, 1523-1526.
43. ROBAK, J. & GRYGLEWSKI, R.J. (1988). Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol., 37, 837-841.
44. ROTONDO, S., RAJTAR, G., MANARINI, S., CELARDO, A., ROTILLO, D., DE GAETANO, G., EVANGELISTA, V. & CERLETT, C. (1998). Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br. J Pharmacol., 123, 1691-1699.
45. SALVEMINI, D., MISKO, T.P., MASFERRER, J.L., SEIBERT, K., CURRIE, M.G. & NEEDLEMAN, P. (1993). Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U.S.A., 90, 7240-7244.
46. SATO, M., SUZUKI, Y., OKUDA, T. & YOKOTSUKA, K. (1997). Contents of resveratrol, piceid, and their isomers in commercially available wines made from grapes cultivated in Japan. Biosci. Biotech. Biochem., 61, 1800-1805.
47. SCHMIDT-KASTNER, R. & FREUND, T.F. (1991). Selective vulnerability of the hippocampus in brain ischemia. Neuroscience, 40, 599-636.
48. SHUTENKO, Z., HENRY, Y., PINARD, E., SEYLAZ, J., POTIER, P., BERTHET, F., GIRARD, P. & SERCOMBE, R. (1999). Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochem. Pharmacol., 57, 199-208.
49. SIMS, N.R. (1996). Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer's disease. Neurodegeneration, 5, 435-440.
50. SOLEAS, G.J., DIAMANDIS, E.P. & GOLDBERG, D.M. (1997). Resveratrol: a molecule whose time has come? And gone? Clin. Biochem., 30, 91-113.
51. STEWART, J.R., WARD, N.E., IOANNIDES, C.G. & O'BRIAN, C.A. (1999). Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. Biochemistry, 33, 13244-13251.
52. SUBBARAMAIAH, K., CHUNG, W.J., MICHALUART, P., TELANG, N., TANABE, T., INOUE, H., JANG, M., PEZZUTO, J.M. & DANNENBERG, A.J. (1998). Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273, 21875-21882.
53. SUBIRADE, I., FERNANDEZ, I., FERNANDEZ, Y., PERIQUET, A. & MITJAVILA, S. (1995). Catechin protection of 3T3 Swiss fibroblasts in culture under oxidative stress. Biol. Trace Element Res., 47, 313-319.
54. SWIERKOSZ, T.A., MITCHELL, J.A., WARNER, T.D., BOTTING, R.M. & VANE, J.R. (1995). Co-induction of nitrite oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br. J. Pharmacol., 114, 1335-1342.
55. TETSUKA, T., DAPHNA-IKEN, D., SRIVASTAVA, S.K., BAIER, L.D., DUMAINE, J. & MORRISON, A.R. (1994). Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc. Natl. Acad. Sci. U.S.A., 91, 112168-12172.
56. TSAI, S.H., LIN-SHIAU, S.Y. & LIN, J.K. (1999). Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br. J. Pharmacol., 126, 673-680.
57. VAN GOLDE, P.H., SLOOTS, L.M., VERMEULEN, W.P., WIELDERS, J.P., HART, H.C., BOUMA, B.N. & VAN DE WIEL, A. (1999). The role of alcohol in the anti low density lipoprotein oxidation activity of red wine. Atherosclerosis, 147, 365-370.
58. VIRGILI, M. & CONTESTABILE, A. (2000). Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett., 281, 123-126.